CytRx Corp. $CYTR – end of day report for June 10, 2021

on June 10, 2021 End of Day Reports and Tags: , with 0 comments
Close:
3.10
Change:
55%
Read more

$CYTR CytRx Notes Topline Data From Trial of Arimoclomol in Amyotrophic Lateral Sclerosis

on May 7, 2021 News and Tags: , , , , , , , with 0 comments
Time:
4:00 PM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire News Releases
Read more

$CYTR CytRx Notes Orphazyme’s Announcement of Topline Results from Trial for Arimoclomol in the Treatment of Inclusion Body Myositis

on April 1, 2021 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire News Releases
Read more

$CYTR CytRx Highlights Orphazyme’s Momentum Ahead of Potential Regulatory Approval of Arimoclomol for Niemann-Pick Disease Type C

on March 8, 2021 News and Tags: , , , , , , , with 0 comments
Time:
8:00 AM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire News Releases
Read more

$CYTR CytRx Highlights Orphazyme’s Appointment of New CEO Ahead of Potential Regulatory Approval of Arimoclomol for Niemann-Pick Disease Type C

on March 4, 2021 News and Tags: , , , , , , , with 0 comments
Time:
8:00 AM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire News Releases
Read more

$CYTR CytRx to Participate in Upcoming Investor Conferences

on March 3, 2021 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire News Releases
Read more

$CYTR CytRx is Added to the LD Micro Index

on February 11, 2021 News and Tags: , , , , , , , with 0 comments
Time:
8:00 AM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire News Releases
Read more